The Medical and Surgical Practice of NaProTECHNOLOGY, 407-412, 2004
Chapter 33: Osteoporosis and Role of CrMS
Author affiliations
- Pope Paul VI Institute for the Study of Human Reproduction, Omaha, Nebraska. ROR
Abstract
Chronic anovulation and progesterone or estradiol deficiency identified through CrMS charting represent periods of suboptimal bone accrual in women of reproductive age, because both estradiol and progesterone contribute to skeletal maintenance -- estradiol through suppression of osteoclast activity and progesterone through osteoblast stimulation. NaProTECHNOLOGY uses longitudinal CrMS records of ovulatory status and hormone profiles as a bone-health risk screen, guiding cycle-synchronized bioidentical hormone replacement to restore normal estrogen-progesterone balance and potentially mitigate progression toward osteoporosis in women with chronic cycle-based endocrine deficiencies.
Topics
Cite this article
Hilgers, T. W. (2004). Chapter 33: Osteoporosis and Role of CrMS. *The Medical and Surgical Practice of NaProTECHNOLOGY*, 407-412.
Hilgers TW. Chapter 33: Osteoporosis and Role of CrMS. The Medical and Surgical Practice of NaProTECHNOLOGY. 2004:407-412.
Hilgers, T. W. "Chapter 33: Osteoporosis and Role of CrMS." *The Medical and Surgical Practice of NaProTECHNOLOGY*, 2004, pp. 407-412.